Investor profile
Novalis Biotech Acceleration fund has backed 3 European tech companies across 3 funding rounds between 2021 and 2022, joining rounds totalling €6.5M. Most active in Healthtech. Data as of 7 Aug 2026.
Also recorded as: Novalis Biotech Acceleration
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Trince | Belgium | 1 | €4.0M |
| Carroucell | France | 1 | €1.5M |
| Alithea Genomics | Switzerland | 1 | €1.0M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Trince | Other | €4.0M | 2021-12 |
| Carroucell | Series A | €1.5M | 2022-09 |
| Alithea Genomics | Other | €1.0M | 2022-05 |
